Renowned Japanese bridal jewellery brand I-PRIMO announces opening of Southeast Asia flagship store in Singapore

3 years ago

SINGAPORE - Media OutReach - 6 December 2022 - Renowned Japanese bridal jewellery brand, I-PRIMO, has officially opened its first…

3 years ago

SINGAPORE - Media OutReach - 6 December 2022 - Global C-Pop star Tia Lee Yu Fen's record-breaking animation series -…

Global C-Pop star Tia Lee back with a bang, spearheads female empowerment with “GOODBYE PRINCESS” animation series

3 years ago

HONG KONG SAR - Media OutReach - 6 December 2022 - Tia Lee (Lee Yu Fen), global C-pop star and…

Blue Cross Launches Mega Sale?79% off on Travel Smart Single Trip Cover

3 years ago

HONG KONG SAR - Media OutReach - 6 December 2022 - With the gradual lifting and eventually removal of entry…

145K Shopee Sellers Achieved 25% Growth In 2022

3 years ago

Superior customer service and optimised storefronts drive economic inclusion KUALA LUMPUR, MALAYSIA - Media OutReach - 6 December 2022 -…

OrBit Markets Launches Staking Yield Swaps

3 years ago

SINGAPORE--(BUSINESS WIRE)--#crypto--OrBit Markets, the leading institutional liquidity provider in digital asset options and structured products, has launched an innovative product…

3 years ago

The new series simplifies manufacture as the battery can be easily connected during battery pack assembly without risk of blowing…

3 years ago

SINGAPORE--(BUSINESS WIRE)--The collapse of the cryptocurrency exchange FTX highlights the importance of effective corporate governance, according to a new AM…

Oasys Completes Strategic Funding Round From Galaxy Interactive and Nexon

3 years ago

The gaming blockchain also announces the conclusion of its five day public token sale, which saw its funding goal reached…

Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

3 years ago

Adagrasib in combination with pembrolizumab demonstrates favorable tolerability and promising preliminary efficacy in patients with first-line advanced/metastatic NSCLC harboring a…